This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Saireudee Chaturantabut: Innovator in Liver Cancer Research
Introduction
Saireudee Chaturantabut is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of liver cancer research through his innovative work. His research focuses on the role of estrogen in liver growth and its implications for abnormal tissue conditions.
Latest Patents
Saireudee holds a patent titled "Estrogen sensing through GPER1 regulates normal and malignant liver growth." This patent outlines methods for the prevention and treatment of abnormal tissue conditions in the liver, such as liver cancer. The invention is based on the administration of an inhibitor of a G protein-coupled estrogen receptor 1 (GPER1). He has 1 patent to his name.
Career Highlights
Saireudee Chaturantabut is affiliated with Brigham and Women's Hospital, Inc., where he conducts his research. His work has garnered attention for its potential to improve treatment options for liver cancer patients.
Collaborations
Saireudee collaborates with Wolfram Goessling, a fellow researcher in the field. Their partnership enhances the depth and breadth of their research efforts.
Conclusion
Saireudee Chaturantabut is a dedicated inventor whose work in liver cancer research is paving the way for new treatment methodologies. His contributions are vital to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile